DAN Margolis, MD Joins Stratagen Bio Clinical Advisory Board
6/6/2024
Stratagen Bio is thrilled to welcome Dan Margolis, MD as a Clinical Advisor. Dr. Margolis is a diagnostic radiologist at Weill Cornell Medicine where he focuses on prostate MRI. He has previously served on the PI-RADS Steering Committee for the American College of Radiology where has crafted the current prostate cancer MRI guidelines and the Quantitative Imaging Biomarker Committee for the Radiological Society of North America.
Stratagen Bio named a Grand Prize Winner of the 2024 Harvard President’s Innovation Challenge
5/3/2024
Stratagen Bio was selected as a Grand Prize Winner of the 2024 Harvard President’s Innovation Challenge and was recognized at the top health and life sciences company founded by an alumni or affiliate. Stratagen CEO, Greg Ekchian, presented to a sold-out crowd in Klarman Hall on the Harvard Business School campus along with 24 other finalists across 5 tracks.
Stratagen Bio named a Finalist of the 2024 Harvard President’s Innovation Challenge
3/28/2024
Stratagen Bio was named as one of 25 finalists of the 2024 Harvard President’s Innovation Challenge. Stratagen will present along side fellow finalists on May 1st at Klarman Hall on the Harvard Business School campus.
Nicholas Zwart, PHD Joins Stratagen Bio as VP of Software Engineering
3/1/2024
Stratagen is extremely excited to welcome Nick Zwart, PhD as Vice President of Software Engineering. Nick brings 20 years of experience in the field of MRI and extensive experience developing software for companies developing novel medical technologies in the imaging and diagnostic space including Hyperfine and Synex Medical.
Gunnar Schaefer
4/1/2023
Stratagen Bio is very happy to welcome Gunnar Schaefer to our Strategic Advisor Board. Gunnar is an software engineer who co-founded and served as Chief Technology Officer of Flywheel.io. Flywheel is a medical imaging AI platform and was based on Gunnars work at Stanford.
2048 Ventures Invests in Stratagen Bio
2/15/2024
Stratagen Bio is thrilled to join the 2048 Ventures family!
Paul Nguyen, MD
2/10/2023
Stratagen Bio welcomes Dr. Paul Nguyen as a Clinical Advisor. Dr. Nguyen is a leader in the field of Prostate Radiation Oncology and has pioneered the adoption of a number of novel technologies into the prostate cancer workflow to improve patient outcomes. Dr. Nguyen currently serves as the Director of Geurounrinary Care in the Department of Radiation Oncology at Dana-Farber/Harvard Cancer Center.